Updates are available Correction dated 2021-04-17
Click to view Correction: https://doi.org/10.1186/s12933-021-01269-8
-
Authors
Yubero-Serrano, Elena M.
Alcalá-Diaz, Juan F.
Gutierrez-Mariscal, Francisco M.
Arenas-de Larriva, Antonio P.
Peña-Orihuela, Patricia J.
Blanco-Rojo, Ruth
Martinez-Botas, Javier
Torres-Peña, Jose D.
Perez-Martinez, Pablo
Ordovas, Jose M.
Delgado-Lista, Javier
Gómez-Coronado, Diego
Lopez-Miranda, Jose http://orcid.org/0000-0002-8844-0718
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00924937 at ClinicalTrials.govDocuments that mention this clinical trial
Sex-specific differences in intestinal microbiota associated with cardiovascular diseases
https://doi.org/10.1186/s13293-024-00582-7
Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial
https://doi.org/10.1186/s12933-024-02451-4
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
https://doi.org/10.1186/s12933-023-01933-1
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
https://doi.org/10.1007/s00394-022-03080-x
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
https://doi.org/10.1007/s00394-022-02854-7
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
https://doi.org/10.1186/s12933-021-01260-3
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.120.033214
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
https://doi.org/10.1016/j.ahj.2016.04.011
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
https://doi.org/10.1007/s00394-021-02676-z
-
Funding
Funding for this research was provided by:
Cordioprev-CEAS (1/2016)
Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (CVI-7450)
Ministerio de Ciencia, Innovación y Universidades (AGL2012-39615, PID2019-104362RB-100, RTI2018-098113-B-100)
Nicolas Monardes Programm - Servicio Andaluz de Salud (C1-0005-2019)
- License Information
-
More Information
Article History
Received: 7 February 2021
Accepted: 13 March 2021
First Online: 25 March 2021
Change Date: 17 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12933-021-01269-8
Declarations
:
: All the patients gave their written informed consent to participate in the study. Following institutional and Good Clinical Practice guidelines, the Human Investigation Review Committee approved the study protocol at Reina Sofia University Hospital.
: Not applicable.
: The authors declare that they have no competing interests.
